Pseudo-hyperkalaemia in ambulatory samples: the never-ending story?

Nephrol Dial Transplant. 2022 Apr 25;37(5):991-993. doi: 10.1093/ndt/gfab355.

Guillaume Lano^{1

2}, Flora Lefevre¹, Christophe Buffat³, Laurent Schlegel⁴, Emmanuel Dho¹, Rodolphe Jantzen⁵, Noémie Resseguier^{6

7}, Thomas Robert^{1

8}

¹ Centre de néphrologie et transplantation rénale, Hôpital de la conception AP-HM Marseille, France.
² Aix Marseille University, INSERM, INRA, C2VN, Marseille, France.
³ Département de biochimie Hôpital de la conception AP-HM Marseille, France.
⁴ Laboratoire bioesterel, Draguignan, France.
⁵ Department of Public Health, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, AP-HP, Saint-Antoine Hospital, Paris, France.
⁶ Support Unit for Clinical Research and Economic Evaluation, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
⁷ Aix-Marseille University, CEReSS-Health Service Research and Quality of Life Center, Marseille, France.
⁸ MMG, Bioinformatics & Genetics, Aix-Marseille Université, Marseille, France.

No abstract available

Publication types